Article
Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer.
International journal of cancer - 15 Nov 2006
Soh Junichi, Toyooka Shinichi, Aoe Keisuke, Asano Hiroaki, Ichihara Syuji, Katayama Hideki, Hiraki Akio, Kiura Katsuyuki, Aoe Motoi, Sano Yoshifumi, Sugi Kazuro, Shimizu Nobuyoshi, Date Hiroshi
Abstract excerpt
The importance of epidermal growth factor receptor (EGFR) gene mutation has been recognized in nonsmall cell lung cancer (NSCLC), requiring the standardization of mutation screening system including the kind of samples. Here, we examined the EGFR mutation status in 61 pleural fluid samples from NSCLC cases using direct sequencing, nonenriched PCR, mutant-enriched PCR and peptide nucleic acid-locked nucleic acid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
